Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0011570 (
depression
)
172,036
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Depression
disorder is one of the most common psychological recognitions that characterized by sadness, low self-confidence, and disinterest in every activity. Considering evidence showing the effects of
toxoplasmosis
on the psychological disease, this study conducted to investigate the serological and molecular aspects of
Toxoplasma gondii infection
among patients with
depression
. In this study, after selecting the patients with
depression
and control groups under the supervision of a psychologist, the blood samples were collected and the serum samples and buffy coat were separated. The specific anti-Toxoplasma IgG antibodies in serum samples were evaluated using the commercial ELISA kit. Then the desired region of the Toxoplasma B1 gene was amplified using the specific primers. To confirm the specificity of primers to amplify the B1 gene of Toxoplasma, the extracted PCR product was sequenced. The overall prevalence of
toxoplasmosis
in patients with
depression
was 59.8 and 60.19% by ELISA and PCR, respectively. In the control group, the prevalence of Toxoplasma was 56.3 and 40.2% by serology and PCR. There was a significant correlation between the prevalence of
toxoplasmosis
and
depression
. Moreover, a significant difference was found between the variables of age, sex, kind of nutrition, level of education and
toxoplasmosis
among the two cases and control groups. The higher prevalence of Toxoplasma infection among patients with
depression
compared with the control group indicates the probable impact of this parasite on
depression
and exacerbates its symptoms, which requires special attention of specialist physicians and patient's relatives.
...
PMID:Depression and Toxoplasma gondii infection: assess the possible relationship through a seromolecular case-control study. 3272 99
This study aimed to evaluate associations between
toxoplasmosis
and psychiatric disorders in Taiwan based on the National Health Insurance Research Database, Taiwan (1997-2013). Patients newly diagnosed with
toxoplasmosis
formed the case group (n = 259), and the control group included propensity-score matched patients without
toxoplasmosis
(n = 1036). The primary outcome was incidence of psychiatric disorders. Cox proportional hazards regression and stratified analyses were performed to examine risk of developing specific psychiatric disorders between patients with and without
toxoplasmosis
. Patients with
toxoplasmosis
had significantly higher incidence of psychiatric disorders than those without
toxoplasmosis
(P = 0.016). A significant difference was found in numbers of psychiatric disorders between the two groups during 14 years of follow-up (log-rank P < 0.001). Those with
toxoplasmosis
had significantly higher risk of bipolar disorder [adjusted hazard ratio (aHR = 3.60, 95% confidence interval (CI) = 2.07, 7.26),
depression
(aHR = 4.94, 95% CI = 2.15, 11.80) and anxiety (aHR = 5.36, 95% CI = 2.98, 25.88), but no significant between-group differences were found for schizophrenia and other psychiatric disorders. In conclusion, the present nationwide population-based analysis revealed that
Toxoplasma gondii infection
in Taiwan significantly increases the risk for developing bipolar disorder,
depression
and anxiety, but not for schizophrenia and other psychiatric disorders.
...
PMID:Infection with
Toxoplasma gondii
increases the risk of psychiatric disorders in Taiwan: a nationwide population-based cohort study. 3272 56
<< Previous
1
2
3
4
5
6